6 April – We are aware of the problems with our United States site redirecting to this site. Visit us at https://shop.zoetisus.com or call 1-888-963-8471.

Argentina

HOME / APOQUEL


Referencia 6. Data on file, Study report. A161R-AU-12-096.2013. Zoetis Inc.

Referencia 7.  Cosgrove SB, Wren JA, Cleaver DM, et al. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Vet Dermatol. 2013;24(5):479-e114.

Referencia 8. Cosgrove SB, Wren JS, Cleaver DM, et al. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel) in client-owned dogs with atopic dermatitis, Vet Dermatol. 2013;24:587-597.doi:10.1111/vde.12088.

Referencia 9. Data on file. Study report 1962C-60-11-A75. 2013. Zoetis Inc. Referencia 12. Data on file. Study report 6962R-14-10-025. 2013. Zoetis Inc.